The crosstalk of the adipose tissue-specific deletion of NOV/CCN3 improved cardiovascular function, representing a novel therapeutic strategy for obesity-related cardiometabolic dysfunction. Here, CCN3 is linked to obesity due to melanocortin 4 receptor deficiency.